BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 15 analysts with an average price target of $51.35. This is a potential upside of $26.25 (104.58%) from yesterday's end of day stock price of $25.1.

Beam Therapeutics 's activity chart (see below) currently has 50 price targets and 71 ratings on display. The stock rating distribution of BEAM is 35% HOLD and 65% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.68% with an average time for these price targets to be met of 72.14 days.

Highest price target for BEAM is $80, Lowest price target is $24, average price target is $51.35.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 14 are a HOLD (35%), 26 are a BUY (65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$53.66 (203.72%)

$80

3 days ago
(28-Feb-2025)

0/6 (0%)

$53.66 (203.72%)

Buy

$78

$51.66 (196.13%)

$78

4 days ago
(27-Feb-2025)

0/3 (0%)

$50.89 (187.72%)

Hold

$26

$-0.34 (-1.29%)

$24

5 days ago
(26-Feb-2025)

6/7 (85.71%)

$-1.89 (-6.78%)

72

Buy

$39

1 months 2 days ago
(29-Jan-2025)

1/10 (10%)

$12.38 (46.51%)

118

3 months 25 days ago
(06-Nov-2024)

0/2 (0%)

$32.61 (73.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 72.14 days on average for the stock forecasts to be realized with a an average price target met ratio 36.68

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Yanan Zhu with highest potential upside - $78.66

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Greg Harrison with lowest potential downside - -$2.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?